BBVA
CRL icon

Banco Bilbao Vizcaya Argentaria’s Charles River Laboratories CRL Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.14M Buy
13,854
+92
+0.7% +$16.4K 0.02% 367
2026
Q1 		$2.37M Sell
13,762
-207
-1% -$38.4K 0.02% 408
2025
Q4 		$2.79M Sell
13,969
-590
-4% -$107K 0.02% 381
2025
Q3 		$2.28M Buy
14,559
+403
+3% +$64K 0.02% 404
2025
Q2 		$2.15M Buy
14,156
+11,047
+355% +$1.47M 0.02% 395
2025
Q1 		$465K Buy
3,109
+879
+39% +$147K ﹤0.01% 611
2024
Q4 		$411K Sell
2,230
-657
-23% -$127K ﹤0.01% 615
2024
Q3 		$569K Sell
2,887
-410
-12% -$85.2K 0.01% 606
2024
Q2 		$683K Sell
3,297
-734
-18% -$166K 0.01% 584
2024
Q1 		$1.09M Buy
4,031
+1,449
+56% +$346K 0.01% 533
2023
Q4 		$609K Buy
2,582
+219
+9% +$43.1K 0.01% 613
2023
Q3 		$463K Buy
2,363
+921
+64% +$189K 0.01% 633
2023
Q2 		$303K Sell
1,442
-109
-7% -$21.7K ﹤0.01% 670
2023
Q1 		$313K Buy
1,551
+281
+22% +$63.7K ﹤0.01% 671
2022
Q4 		$277K Buy
1,270
+57
+5% +$12.4K ﹤0.01% 666
2022
Q3 		$239K Sell
1,213
-17
-1% -$3.67K ﹤0.01% 683
2022
Q2 		$263K Buy
1,230
+122
+11% +$29.8K ﹤0.01% 650
2022
Q1 		$321K Sell
1,108
-155
-12% -$47.8K ﹤0.01% 657
2021
Q4 		$475K Buy
1,263
+28
+2% +$10.9K 0.01% 677
2021
Q3 		$510K Buy
1,235
+25
+2% +$10.4K 0.01% 612
2021
Q2 		$448K Buy
+1,210
New +$404K 0.01% 639

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's CRL Position: Q2 2026 in Review

Banco Bilbao Vizcaya Argentaria increased its Charles River Laboratories (CRL) stake by 0.67% in Q2 2026, buying an estimated $16.4K and bringing the position to 13,854 shares worth $3.14M. The position accounts for 0.02% of the portfolio, ranked #367.

Banco Bilbao Vizcaya Argentaria first reported a position in CRL in Q2 2021 and has held it in 21 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Banco Bilbao Vizcaya Argentaria held 13,854 shares of Charles River Laboratories worth $3.14M as of Q2 2026.
  • Banco Bilbao Vizcaya Argentaria bought 92 Charles River Laboratories shares in Q2 2026, an estimated $16.4K.
  • Charles River Laboratories made up 0.02% of Banco Bilbao Vizcaya Argentaria's portfolio in Q2 2026, its #367 holding.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Charles River Laboratories in Q2 2021 and has held it in 21 quarters since.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q2 2026, filed 12 Aug 2026.